Aromatic Beta-Blocker Atenolol from Japan
Atenolol is a synthetic aromatic beta-blocker drug used primarily for treating hypertension and angina. It falls under HTS 2942.00.05.00 as an aromatic organic compound classified as a drug, distinct from standard pharmaceuticals in Chapters 29 or 30. This code applies to specific aromatic or modified aromatic drugs not covered elsewhere.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Verify drug status with FDA registration and provide Certificate of Analysis confirming aromatic structure
• Ensure compliance with DEA scheduling if applicable; avoid misclassification as Chapter 30 finished dosage forms
• Include stability data for transport as per Chapter 29 note (f) to prevent reclassification